When PCa recurrence occurs or when patients with PCa are diagnosed with advanced stages, main therapy becomes androgen ablation using luteinizing hormone releasing hormone (LHRH) agonists and antagonists and/or anti-androgen receptors (ARs) [7,8]. The gene discussed is AR; the disease is posterior cortical atrophy.